A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML.

Blood Neoplasia · 2025 · PMC12067906 · PMID 40453133

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Using a log-rank test and univariate Cox model, female sex and DAC/ATO therapy correlated with longer survival, although this did not reach statistical significance (not shown).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.